Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Transplant with Consolidation Chemotherapy in Multiple Myeloma
NCT00003399Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Sep 1998
- Primary completion
- Sep 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine, melphalan, cyclophosphamide, dexamethasone, etoposide in multiple myeloma (MM), sponsored by University of Maryland, Baltimore. Started Sep 1998; status: completed.
02
Drugs
carmustinemelphalancyclophosphamidedexamethasoneetoposide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00003399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003399.